[Leukorrhea: diagnostic trends].
Lanta
S
S
Service de gynécologie-obstétrique, Université de Picardie Jules-Verne, centre hospitalier universitaire, Amiens.
Mention
J E
JE
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002648:Child; D004716:Endometritis / Q000150:complications / Q000175:diagnosis / Q000382:microbiology; D005260:Female; D006801:Humans; D007973:Leukorrhea / Q000175:diagnosis* / Q000209:etiology; D008795:Metronidazole / Q000627:therapeutic use; D008828:Microbiological Techniques; D008875:Middle Aged; D011247:Pregnancy; D014247:Trichomonas Vaginitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002575:Uterine Cervicitis / Q000150:complications / Q000175:diagnosis / Q000382:microbiology; D014621:Vagina / Q000378:metabolism / Q000382:microbiology; D014848:Vulvovaginitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000994:Antitrichomonal Agents; D008795:Metronidazole